 Shares of Progenity Inc. PROG, 3.59 gained 4.9 in trading on Wednesday after the company said it received four patents from the U.S. Patent and Trademark Office related to its ingestible technologies that can be used to deliver medicine to the gastrointestinal tract. Progenitys stock has tumbled 56.0 so far this year, while the SP 500 SPX, -0.15 is up 15.8. 